We are live on ! Find out more
DADC

D.A. Davidson & Co Portfolio holdings

AUM $18.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+2.55%
1 Year Est. Return
+24.63%
3 Year Est. Return
+70.71%
5 Year Est. Return
+77.77%
10 Year Est. Return
+255.18%
AUM
$4.43B
AUM Growth
+$304M
Cap. Flow
+$215M
Cap. Flow %
4.85%
Top 10 Hldgs %
28.31%
Holding
2,533
New
165
Increased
888
Reduced
729
Closed
137

Top Sells

Rank Stock Value
1
KRC icon
Kilroy Realty
KRC
+$14.6M
2
ABBV icon
AbbVie
ABBV
+$7.15M
3
CAG icon
Conagra Brands
CAG
+$6.73M
4
KBR icon
KBR
KBR
+$4.75M
5
DE icon
Deere & Co
DE
+$4.43M

Sector Composition

Rank Sector Weight
1 Healthcare 9.11%
2 Technology 8.74%
3 Industrials 8.05%
4 Financials 7.99%
5 Consumer Discretionary 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCP
1951
DELISTED
DCP Midstream, LP
DCP
$12K ﹤0.01%
361
+6
+2% +$214
IVH
1952
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
$12K ﹤0.01%
800
-700
-47% -$11K
TSG
1953
DELISTED
The Stars Group Inc.
TSG
$12K ﹤0.01%
700
BSJI
1954
DELISTED
Invesco BulletShares 2018 High Yield Corporate Bond ETF
BSJI
$12K ﹤0.01%
500
ANTH
1955
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$12K ﹤0.01%
8,016
-4,628
-37% -$10.4K
SNAK
1956
DELISTED
Inventure Foods, Inc.
SNAK
$12K ﹤0.01%
2,929
CFCOU
1957
DELISTED
CF Corporation
CFCOU
$12K ﹤0.01%
1,000
IBDM
1958
DELISTED
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
$12K ﹤0.01%
500
-700
-58% -$17.5K
VXX
1959
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$12K ﹤0.01%
+250
New +$14.5K
ALNY icon
1960
Alnylam Pharmaceuticals
ALNY
$36.3B
$11K ﹤0.01%
150
+10
+7% +$639
AOS icon
1961
A.O. Smith
AOS
$8.38B
$11K ﹤0.01%
204
BCRX icon
1962
BioCryst Pharmaceuticals
BCRX
$2.37B
$11K ﹤0.01%
2,000
-3,000
-60% -$18.3K
DBA icon
1963
Invesco DB Agriculture Fund
DBA
$1.26B
$11K ﹤0.01%
+600
New +$11.8K
DHF
1964
BNY Mellon High Yield Strategies Fund
DHF
$171M
$11K ﹤0.01%
3,284
FEMS icon
1965
First Trust Emerging Markets Small Cap AlphaDEX Fund
FEMS
$245M
$11K ﹤0.01%
300
GUNR icon
1966
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.19B
$11K ﹤0.01%
+401
New +$11.7K
KLAC icon
1967
KLA
KLAC
$275B
$11K ﹤0.01%
1,290
LOB icon
1968
Live Oak Bancshares
LOB
$1.95B
$11K ﹤0.01%
455
-416
-48% -$9.95K
MOO icon
1969
VanEck Agribusiness ETF
MOO
$989M
$11K ﹤0.01%
200
MUSA icon
1970
Murphy USA
MUSA
$11.3B
$11K ﹤0.01%
150
NFG icon
1971
National Fuel Gas
NFG
$7.84B
$11K ﹤0.01%
200
-250
-56% -$14.1K
ORA icon
1972
Ormat Technologies
ORA
$6.11B
$11K ﹤0.01%
200
PBF icon
1973
PBF Energy
PBF
$7.29B
$11K ﹤0.01%
500
-550
-52% -$11.8K
PFL
1974
PIMCO Income Strategy Fund
PFL
$381M
$11K ﹤0.01%
1,000
REXR icon
1975
Rexford Industrial Realty
REXR
$8.7B
$11K ﹤0.01%
421
-36
-8% -$936

Similar funds

D.A. Davidson & Co's Q2 2017 Portfolio in Review

As of Q2 2017, D.A. Davidson & Co held 2,533 positions worth $4.43B, up 7.4% from $4.12B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

D.A. Davidson & Co deployed $215M of net new capital in Q2 2017, opening 165 new positions and adding to 888 existing holdings. Its largest new stake was AutoZone: 2,429 shares worth $1.39M.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, up from 9% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was AbbVie, an estimated $7.15M trimmed.

  • D.A. Davidson & Co's largest Q2 2017 buy was AutoZone: 2,429 shares worth $1.39M.
  • D.A. Davidson & Co added most to Vanguard Value ETF in Q2 2017, an estimated $20.9M increase.
  • D.A. Davidson & Co's biggest Q2 2017 reduction was AbbVie, cutting an estimated $7.15M.
  • D.A. Davidson & Co fully exited Kilroy Realty in Q2 2017, selling an estimated $14.6M.
  • D.A. Davidson & Co's ten largest holdings make up 28% of its $4.43B portfolio in Q2 2017.
  • D.A. Davidson & Co opened 165 new positions and closed 137 in Q2 2017.
  • D.A. Davidson & Co's portfolio value rose 7.4% quarter-over-quarter to $4.43B.

Based on D.A. Davidson & Co's 13F filing for Q2 2017, filed 11 Aug 2017.